REFERENCES
1. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach–results of the first prospective study of the International Society of Pediatric Oncology.J Clin Oncol . Nov 15 2000;18(22):3819-28. doi:10.1200/JCO.2000.18.22.3819
2. Ramos-Gonzalez G, LaQuaglia M, O’Neill AF, et al. Long-term outcomes of liver transplantation for hepatoblastoma: A single-center 14-year experience. Pediatr Transplant . Jun 11 2018:e13250. doi:10.1111/petr.13250
3. Kasahara M, Ueda M, Haga H, et al. Living-donor liver transplantation for hepatoblastoma. Am J Transplant . Sep 2005;5(9):2229-35. doi:10.1111/j.1600-6143.2005.01003.x
4. Sakamoto S, Kasahara M, Mizuta K, et al. Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan. Liver Transpl . Mar 2014;20(3):333-46. doi:10.1002/lt.23803
5. Kueht M, Thompson P, Rana A, Cotton R, O’Mahony C, Goss J. Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children’s Hospital.Pediatr Transplant . Jun 2016;20(4):515-22. doi:10.1111/petr.12699
6. Umeda K, Okajima H, Kawaguchi K, et al. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: A single-institute experience. Pediatr Transplant . Mar 2018;22(2)doi:10.1111/petr.13113
7. Pimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery. J Pediatr Surg . Feb 2002;37(2):240-5. doi:10.1053/jpsu.2002.30264
8. Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr . Feb 2014;26(1):29-36. doi:10.1097/MOP.0000000000000042
9. Neto JS, Pugliese R, Fonseca EA, et al. Four hundred thirty consecutive pediatric living donor liver transplants: variables associated with posttransplant patient and graft survival. Liver Transpl . May 2012;18(5):577-84. doi:10.1002/lt.23393
10. Neto JS, Carone E, Pugliese V, et al. Living donor liver transplantation for children in Brazil weighing less than 10 kilograms. Liver Transpl . Aug 2007;13(8):1153-8. doi:10.1002/lt.21206
11. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma– results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer . Jul 2000;36(11):1418-25. doi:10.1016/s0959-8049(00)00074-5
12. Malogolowkin MH, Katzenstein HM, Krailo M, Meyers RL. Treatment of hepatoblastoma: the North American cooperative group experience. Front Biosci (Elite Ed) . Jan 1 2012;4:1717-23. doi:10.2741/492
13. Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer . Jan 2004;42(1):74-83. doi:10.1002/pbc.10376
14. Meyers RL, Czauderna P, Otte JB. Surgical treatment of hepatoblastoma. Pediatr Blood Cancer . Nov 2012;59(5):800-8. doi:10.1002/pbc.24220
15. Otte JB. Progress in the surgical treatment of malignant liver tumors in children. Cancer Treat Rev . Jun 2010;36(4):360-71. doi:10.1016/j.ctrv.2010.02.013
16. Czauderna P, Haeberle B, Hiyama E, et al. The Children’s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer . Jan 2016;52:92-101. doi:10.1016/j.ejca.2015.09.023
17. Browne M, Sher D, Grant D, et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg . Nov 2008;43(11):1973-81. doi:10.1016/j.jpedsurg.2008.05.031
18. Isono K, Ohya Y, Lee KJ, et al. Pretransplant trends in alpha-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience. Pediatr Transplant . Aug 2018;22(5):e13221. doi:10.1111/petr.13221
19. Lauferman L, Halac E, Aredes D, et al. Prognostic factors for event-free survival in liver transplantation for hepatoblastoma: A single-center experience.Pediatr Transplant . Dec 2019;23(8):e13581. doi:10.1111/petr.13581
20. Avila LF, Encinas JL, Leal N, et al. [Liver transplatation for malignant tumors in children].Cir Pediatr . Oct 2007;20(4):189-93. Trasplante hepatico en tumores malignos en el nino.
21. Casas-Melley AT, Malatack J, Consolini D, et al. Successful liver transplant for unresectable hepatoblastoma. J Pediatr Surg . Jan 2007;42(1):184-7. doi:10.1016/j.jpedsurg.2006.09.017
22. Otte JB, de Ville de Goyet J. The contribution of transplantation to the treatment of liver tumors in children. Semin Pediatr Surg . Nov 2005;14(4):233-8. doi:10.1053/j.sempedsurg.2005.06.006
23. De Ioris M, Brugieres L, Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer . Mar 2008;44(4):545-50. doi:10.1016/j.ejca.2007.11.022
24. Marin JJG, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias RIR. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers (Basel) . Mar 22 2019;11(3)doi:10.3390/cancers11030407
25. Candido HL, da Fonseca EA, Feier FH, et al. Risk Factors Associated with Increased Morbidity in Living Liver Donation. J Transplant . 2015;2015:949674. doi:10.1155/2015/949674
26. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl . Oct 2006;12(10):1485-8. doi:10.1002/lt.20875
27. Reyes JD, Carr B, Dvorchik I, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr . Jun 2000;136(6):795-804.
28. von Schweinitz D, Wischmeyer P, Leuschner I, et al. Clinico-pathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer . 1994;30A(8):1052-8. doi:10.1016/0959-8049(94)90454-5
29. Okur MH, Yankol Y, Cimsit B, et al. Liver Transplant in Children with Hepatoblastoma. Exp Clin Transplant . Oct 2019;17(5):644-647. doi:10.6002/ect.2016.0110